Vincent Alcazer, MD

Hematology, Centre Leon Berard
Lyon France Papers:
48 First-Line Second Generation Tyrosine Kinase Inhibitors in Newly Diagnosed Accelerated Phase Chronic Myeloid Leukemia Patients.
3014 Deep Molecular Response in Imatinib First-Line 418 Newly Diagnosed CP CML Patients.